Press Releases
October 15, 2024
Debiopharm to Showcase Research Results of Their First-In-Class Anti-Staphylococcal Program at IDWeek 2024 in Los Angeles
February 26, 2019
Debiopharm International SA Initiates a Clinical Trial Phase II study evaluating afabicin in Bone and Joint Infections
April 8, 2016
Debiopharm International SA to present the latest findings on Debio 1450 at ECCMID